Schneider, T., Heußel, C. P., Umansky, L., Beckhove, P., Dienemann, H., Safi, S., . . . Umansky, V. (2015). Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. Clinical & experimental immunology, 180(3), . https://doi.org/10.1111/cei.12596
Chicago Style (17th ed.) CitationSchneider, Thomas, Claus Peter Heußel, Ludmila Umansky, Philipp Beckhove, Hendrik Dienemann, Seyer Safi, Jochen Utikal, Hans Hoffmann, and Viktor Umansky. "Serum Inflammatory Factors and Circulating Immunosuppressive Cells Are Predictive Markers for Efficacy of Radiofrequency Ablation in Non-small-cell Lung Cancer." Clinical & Experimental Immunology 180, no. 3 (2015). https://doi.org/10.1111/cei.12596.
MLA (9th ed.) CitationSchneider, Thomas, et al. "Serum Inflammatory Factors and Circulating Immunosuppressive Cells Are Predictive Markers for Efficacy of Radiofrequency Ablation in Non-small-cell Lung Cancer." Clinical & Experimental Immunology, vol. 180, no. 3, 2015, https://doi.org/10.1111/cei.12596.